Cargando…

Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) — a protocol for two parallel, open-label, randomised controlled trials

BACKGROUND: Universal immunisation is the cornerstone of preventive medicine for children, The World Health Organisation (WHO) recommends diphtheria-tetanus-pertussis (DTP) vaccine administered at 6, 10 and 14 weeks of age as part of routine immunisation. However, globally, more than 17 unique DTP-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Sarah, Liu, Xinxue, Theiss-Nyland, Katherine, Voysey, Merryn, Murphy, Sarah, Li, Grace, Nyantaro, Mary, Gurung, Meeru, Basnet, Sudha, Pokhrel, Bhishma, Bijukchhe, Sanjeev M., Eordogh, Agnes, Gombe, Ben, Kakande, Ayoub, Kerridge, Simon, Kimbugwe, Geofrey, Kusemererwa, Sylvia, Lubyayi, Lawrence, Luzze, Henry, Mazur, Olga, Mujadidi, Yama F., Nabukenya, Shamim, Nagumo, Walter-Rodney, Nareeba, Tryphena, Noristani, Rabiullah, O’Reilly, Peter, Roberts, Andrew, Shah, Ganesh, Shrestha, Sonu, Shrestha, Laxman P., Thapa, Surya B., Kibengo, Freddie M., Sharma, Arun K., Elliott, Alison, Shrestha, Shrijana, Pollard, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360224/
https://www.ncbi.nlm.nih.gov/pubmed/37480110
http://dx.doi.org/10.1186/s13063-023-07477-9
Descripción
Sumario:BACKGROUND: Universal immunisation is the cornerstone of preventive medicine for children, The World Health Organisation (WHO) recommends diphtheria-tetanus-pertussis (DTP) vaccine administered at 6, 10 and 14 weeks of age as part of routine immunisation. However, globally, more than 17 unique DTP-containing vaccine schedules are in use. New vaccines for other diseases continue to be introduced into the infant immunisation schedule, resulting in an increasingly crowded schedule. The OptImms trial will assess whether antibody titres against pertussis and other antigens in childhood can be maintained whilst adjusting the current Expanded Programme on Immunisation (EPI) schedule to provide space for the introduction of new vaccines. METHODS: The OptImms studies are two randomised, five-arm, non-inferiority clinical trials in Nepal and Uganda. Infants aged 6 weeks will be randomised to one of five primary vaccination schedules based on age at first DTwP-vaccination (6 versus 8 weeks of age), number of doses in the DTwP priming series (two versus three), and spacing of priming series vaccinations (4 versus 8 weeks). Additionally, participants will be randomised to receive their DTwP booster at 9 or 12 months of age. A further sub-study will compare the co-administration of typhoid vaccine with other routine vaccines at one year of age. The primary outcome is anti-pertussis toxin IgG antibodies measured at the time of the booster dose. Secondary outcomes include antibodies against other vaccine antigens in the primary schedule and their safety. DISCUSSION: These data will provide key data to inform policy decisions on streamlining vaccination schedules in childhood. TRIAL REGISTRATIONS: ISRCTN12240140 (Nepa1, 7(th) January 2021) and ISRCTN6036654 (Uganda, 17(th) February 2021). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07477-9.